| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,288 |
2,772 |
$151K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
861 |
770 |
$51K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
427 |
363 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,296 |
2,112 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
758 |
691 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
461 |
427 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
349 |
291 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
147 |
141 |
$5K |
| 86328 |
|
125 |
101 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
306 |
265 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
239 |
202 |
$936.50 |
| 36415 |
Collection of venous blood by venipuncture |
362 |
311 |
$397.81 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
102 |
91 |
$148.61 |
| 87420 |
|
14 |
12 |
$135.24 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17 |
12 |
$126.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
47 |
$49.91 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
60 |
49 |
$36.49 |